General Trading Chat

These are company deposits and are unsecured. Bank Deposits comes with guarantee just 1 lakh Rs and not 10 Lakh.

Below from RBI Site
Seems Government Securities (G-Secs) are more safer than FD, as stated by Zerodha :
Sovereign Guarantee
Unlike other fixed income products like bank FD's, debt funds etc that carry a credit risk, G-Secs are guaranteed by Govt. of India.
 
So, India's exports fell last month. Maybe USDINR will react badly tomorrow.

Amid trade tensions, India's June exports fall 9.7% to $25 billion
1 min read . Updated: 15 Jul 2019, 07:44 PM ISTAsit Ranjan Mishra
  • June trade deficit narrows to $15.28 billion; merchandise imports decrease 9.06% to $40.29 bn
  • The escalating trade war between the US and China and rising protectionism have cast a shadow on India’s prospects for higher exports
https://www.livemint.com/news/india...rts-fall-9-7-to-25-billion-1563199917049.html
 
Ashok Leyland has been looking for an excuse to go down. Maybe now is a good time.

1563206220585.png


Ashok Leyland temporarily shuts Pantnagar plant for nine days over weak demand
1 min read . Updated: 15 Jul 2019, 07:53 PM ISTAmit Panday
  • Industry outlook is another reason that the Pantnagar plant will remain closed from July 16-24
  • Ashok Leyland’s CV production in June stands at 12,690 units, down 21.35% y-o-y
https://www.livemint.com/auto-news/...nine-days-over-weak-demand-1563199302295.html
 

Riskyman

Well-Known Member
@timepass Seeing this across all sectors.

India slowdown to increase profitability challenges for pharma companies in Q1

Mumbai: Data from pharmaceutical market research company AIOCD Pharmasofttech AWACS Pvt. Ltd shows that growth in Indian pharmaceutical market dropped to a seven quarter low between April and June this year.

“1Q FY20 market growth stood at 7.9%, the slowest in the past seven quarters and one of the lowest in past five year," Jefferies India Pvt. Ltd said in a note, citing the AIOCD data. The deepening slowdown in the Indian drug market will intensify profitability challenges for pharmaceutical companies.

https://www.livemint.com/market/mar...for-pharma-companies-in-q1-1563190054050.html
 

Similar threads